253 related articles for article (PubMed ID: 16996766)
1. Stop codon mutations in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population.
Yamazaki H; Fujita H; Gunji T; Zhang J; Kamataki T; Cashman JR; Shimizu M
Mol Genet Metab; 2007 Jan; 90(1):58-63. PubMed ID: 16996766
[TBL] [Abstract][Full Text] [Related]
2. Variants in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population.
Shimizu M; Kobayashi Y; Hayashi S; Aoki Y; Yamazaki H
Mol Genet Metab; 2012 Nov; 107(3):330-4. PubMed ID: 22819296
[TBL] [Abstract][Full Text] [Related]
3. Novel variants and haplotypes of human
Shimizu M; Yoda H; Igarashi N; Makino M; Tokuyama E; Yamazaki H
Xenobiotica; 2019 Oct; 49(10):1244-1250. PubMed ID: 30351217
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of the flavin-containing monooxygenase 3 (FMO3) associated with trimethylaminuria (fish odor syndrome): observations from Japanese patients.
Yamazaki H; Shimizu M
Curr Drug Metab; 2007 Jun; 8(5):487-91. PubMed ID: 17584019
[TBL] [Abstract][Full Text] [Related]
5. Trimethylaminuria is caused by mutations of the FMO3 gene in a North American cohort.
Akerman BR; Lemass H; Chow LM; Lambert DM; Greenberg C; Bibeau C; Mamer OA; Treacy EP
Mol Genet Metab; 1999 Sep; 68(1):24-31. PubMed ID: 10479479
[TBL] [Abstract][Full Text] [Related]
6. Trimethylaminuria (fish odor syndrome): genotype characterization among Portuguese patients.
Ferreira F; Esteves S; Almeida LS; Gaspar A; da Costa CD; Janeiro P; Bandeira A; Martins E; Teles EL; Garcia P; Azevedo L; Vilarinho L
Gene; 2013 Sep; 527(1):366-70. PubMed ID: 23791655
[TBL] [Abstract][Full Text] [Related]
7. Effect of genetic variants of the human flavin-containing monooxygenase 3 on N- and S-oxygenation activities.
Shimizu M; Yano H; Nagashima S; Murayama N; Zhang J; Cashman JR; Yamazaki H
Drug Metab Dispos; 2007 Mar; 35(3):328-30. PubMed ID: 17142560
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants of flavin-containing monooxygenase 3 (FMO3) derived from Japanese subjects with the trimethylaminuria phenotype and whole-genome sequence data from a large Japanese database.
Shimizu M; Yoda H; Nakakuki K; Saso A; Saito I; Hishinuma E; Saito S; Hiratsuka M; Yamazaki H
Drug Metab Pharmacokinet; 2019 Oct; 34(5):334-339. PubMed ID: 31401033
[TBL] [Abstract][Full Text] [Related]
9. Human flavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria.
Cashman JR; Bi YA; Lin J; Youil R; Knight M; Forrest S; Treacy E
Chem Res Toxicol; 1997 Aug; 10(8):837-41. PubMed ID: 9282831
[TBL] [Abstract][Full Text] [Related]
10. A nonsense mutation in the FMO3 gene underlies fishy off-flavor in cow's milk.
Lundén A; Marklund S; Gustafsson V; Andersson L
Genome Res; 2002 Dec; 12(12):1885-8. PubMed ID: 12466292
[TBL] [Abstract][Full Text] [Related]
11. Two novel mutations of the FMO3 gene in a proband with trimethylaminuria.
Akerman BR; Forrest S; Chow L; Youil R; Knight M; Treacy EP
Hum Mutat; 1999; 13(5):376-9. PubMed ID: 10338091
[TBL] [Abstract][Full Text] [Related]
12. Transient trimethylaminuria related to menstruation.
Shimizu M; Cashman JR; Yamazaki H
BMC Med Genet; 2007 Jan; 8():2. PubMed ID: 17257434
[TBL] [Abstract][Full Text] [Related]
13. Phenotyping of flavin-containing monooxygenase using caffeine metabolism and genotyping of FMO3 gene in a Korean population.
Park CS; Chung WG; Kang JH; Roh HK; Lee KH; Cha YN
Pharmacogenetics; 1999 Apr; 9(2):155-64. PubMed ID: 10376762
[TBL] [Abstract][Full Text] [Related]
14. Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population.
Shimizu M; Allerston CK; Shephard EA; Yamazaki H; Phillips IR
Br J Clin Pharmacol; 2014 May; 77(5):839-51. PubMed ID: 24028545
[TBL] [Abstract][Full Text] [Related]
15. Novel variants in outer protein surface of flavin-containing monooxygenase 3 found in an Argentinian case with impaired capacity for trimethylamine N-oxygenation.
Dionisio L; Shimizu M; Stupniki S; Oyama S; Aztiria E; Alda M; Yamazaki H; Spitzmaul G
Drug Metab Pharmacokinet; 2020 Aug; 35(4):383-388. PubMed ID: 32653296
[TBL] [Abstract][Full Text] [Related]
16. Trimethylaminuria and a human FMO3 mutation database.
Hernandez D; Addou S; Lee D; Orengo C; Shephard EA; Phillips IR
Hum Mutat; 2003 Sep; 22(3):209-13. PubMed ID: 12938085
[TBL] [Abstract][Full Text] [Related]
17. In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene.
Lambert DM; Mamer OA; Akerman BR; Choinière L; Gaudet D; Hamet P; Treacy EP
Mol Genet Metab; 2001 Jul; 73(3):224-9. PubMed ID: 11461189
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants of flavin-containing monooxygenase 3 (FMO3) in Japanese subjects identified by phenotyping for trimethylaminuria and found in a database of genome resources.
Shimizu M; Koibuchi N; Mizugaki A; Hishinuma E; Saito S; Hiratsuka M; Yamazaki H
Drug Metab Pharmacokinet; 2021 Jun; 38():100387. PubMed ID: 33831674
[TBL] [Abstract][Full Text] [Related]
19. Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuria.
Zhang J; Tran Q; Lattard V; Cashman JR
Pharmacogenetics; 2003 Aug; 13(8):495-500. PubMed ID: 12893987
[TBL] [Abstract][Full Text] [Related]
20. Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication.
Treacy EP; Akerman BR; Chow LM; Youil R; Bibeau C; Lin J; Bruce AG; Knight M; Danks DM; Cashman JR; Forrest SM
Hum Mol Genet; 1998 May; 7(5):839-45. PubMed ID: 9536088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
